Yonghua Investment Management

Yonghua Capital is a prominent Chinese private equity and venture capital firm headquartered in Shanghai, specializing in high-growth sectors including healthcare, biotechnology, and advanced manufacturing. Established in 2001 as the primary investment arm of the Yongjin Group, the firm has built a robust track record with over 100 portfolio companies reaching public markets. In the life sciences space, Yonghua focuses on innovative drug development, high-end medical devices, and molecular diagnostics, providing both capital and strategic resources to help companies navigate the Chinese regulatory and commercial landscape. The firm is recognized for its deep industry expertise and its ability to support companies from early-stage growth through to IPO.